Replacement: Director/PDMR Shareholding

RNS Number : 7507R
HgCapital Trust PLC
07 July 2022
 

07 July 2022

 

HGCAPITAL TRUST PLC (THE "COMPANY")

 

Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Connected Persons

 

The following amendment has been made to the Director / PDMR Shareholding announcement released on 5 July 2022 at 13:43 under RNS Number: 3984R: the name of the PCA of Jim Strang, the Chairman and Non-Executive Director of the Company, should have read Foxy14 Holdings Limited, not Foxy14 Limited.  All other details were correct and the full amended text is shown below.

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Foxy14 Holdings Limited

2.

Reason for the notification

a)

Position / status

This notification concerns a person closely associated with Jim Strang. Foxy14 Holdings Limited is wholly owned by Jim Strang, the Chairman and a Non-Executive Director of the Company and Lynn Strang, a PCA of Jim Strang.

 

b)

Initial notification / amendment

Initial Notification

 

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

HgCapital Trust plc

b)

LEI

213800J7QUJJBEFSIN38

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of 2.5p each

 

ISIN: GB00BJ0LT190

 

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£3.1803

28,250

d)

Aggregated information

Aggregated volume

Price

 

 

28,250

£3.1803

e)

Date of the transaction

4 July 2022

f)

Place of the transaction

London Stock Exchange

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUBWMUPPGAM
UK 100

Latest directors dealings